Racial, Ethnic Disparities Seen in Management of NSTEMI
MONDAY, Aug. 8, 2022 -- In 2017 to 2019, Black and Hispanic individuals were less likely than Whites to undergo coronary angiography and percutaneous coronary intervention for non-ST-segment elevation myocardial infarction, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 8, 2022 Category: Pharmaceuticals Source Type: news

CTO PCI Success Rates Rising, Registry Shows CTO PCI Success Rates Rising, Registry Shows
Updated results from a registry of chronic total occlusion percutaneous coronary angioplasty cases reports improving outcomes over the past 6 years.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 9, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Abbott recalls Dragonfly OpStar Imaging Catheter
Abbott Medical has recalled its Dragonfly OpStar Imaging Catheter because potentia...Read more on AuntMinnie.comRelated Reading: Abbott expands MRI compatibility for Proclaim Abbott recalls 2 coronary angioplasty catheters FDA clears Abbott's ICD for use with MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 26, 2022 Category: Radiology Source Type: news

Chronic Total Occlusion PCI Is Getting Safer -- At Least Until the Pandemic
(MedPage Today) -- ATLANTA -- Percutaneous coronary intervention for chronic total occlusion (CTO PCI) has improved in success rates, but the pandemic might have impacted complication rates, a registry study showed. Technical and procedural... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 21, 2022 Category: Cardiology Source Type: news

Addition of Icosapent Ethyl Cuts CV Risk in Patients With Prior PCI
THURSDAY, March 24, 2022 -- The risk for cardiovascular events is reduced in statin-treated patients with elevated triglycerides and a history of percutaneous coronary intervention (PCI) who receive icosapent ethyl, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2022 Category: Pharmaceuticals Source Type: news

Video: Coronary angioplasty
Coronary angioplasty and stenting open clogged heart arteries and prevent them from narrowing again. Watch this video to find out more about the procedure. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - September 29, 2021 Category: Consumer Health News Source Type: news

Multivessel traumatic coronary artery dissection after a motor vehicle accident with successful percutaneous coronary intervention - Pandey Y, Owen B, Birnbaum G, Tabbaa R, Hamzeh I, Lakkis N, Kayani W.
We report a case of acute left anterior descending and right coronary artery dissections after a motor vehicle accident. The musculoskeletal injuries obscured the cardiac symptom... (Source: SafetyLit)
Source: SafetyLit - July 30, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Medtronic Prevail DCB™ Designed to Treat Complex Lesions with Superior Deliverability, Rapid Absorption of Paclitaxel DUBLIN, July 26, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in medical technology,... Devices, Interventional, Cardiology, Regulatory Medtronic, Prevail DCB, percutaneous coronary intervention (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2021 Category: Pharmaceuticals Source Type: news

Impact of Age Examined for Ticagrelor Monotherapy After PCI
WEDNESDAY, July 7, 2021 -- For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2021 Category: Pharmaceuticals Source Type: news

Ticagrelor, Prasugrel Compared in ACS Treated With PCI
TUESDAY, July 6, 2021 -- For patients presenting with acute coronary syndrome (ACS) who undergo percutaneous coronary intervention (PCI), a postrandomization subgroup analysis suggests that a prasugrel-based strategy is superior to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 6, 2021 Category: Pharmaceuticals Source Type: news

Preventable Risk Factors Widespread in Patients Undergoing Angioplasty
WEDNESDAY, June 23, 2021 -- Modifiable risk factors remain widely prevalent among patients undergoing their first percutaneous coronary intervention (PCI), according to a study published online June 9 in PLOS ONE. Zoya Gurm, from the Wayne State... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 23, 2021 Category: Pharmaceuticals Source Type: news

Physician-patient gender concordance may not matter in interventional practice
(Michigan Medicine - University of Michigan) While some studies suggest female patients treated by female physicians have better outcomes, there does not appear to be a relationship between operator and patient gender and outcome in patients undergoing coronary angioplasty or stenting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2021 Category: International Medicine & Public Health Source Type: news

Stents or bypass surgery more effective for stable patients with high-risk cardiac anatomy
(University of Alberta Faculty of Medicine& Dentistry) A study by University of Alberta cardiologists at the Canadian VIGOUR Centre shows that a particular group of patients with stable ischemic heart disease have better outcomes with percutaneous coronary intervention (also called angioplasty with stent) or coronary artery bypass surgery and medication, versus conservative management with medication alone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 18, 2021 Category: International Medicine & Public Health Source Type: news

Primary PCI Use Down for Cancer Patients With STEMI
WEDNESDAY, Feb. 17, 2021 -- Patients with active cancer who have ST-elevation myocardial infarction (STEMI) receive primary percutaneous coronary intervention (pPCI) less often, but they have significantly lower rates of in-hospital all-cause... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2021 Category: Pharmaceuticals Source Type: news

Cancer patients not receiving life-saving heart attack treatment
(European Society of Cardiology) Emergency heart attack treatment is effective in patients with cancer, yet many do not receive it. That's the finding of a study published on World Cancer Day in European Heart Journal - Acute Cardiovascular Care, a journal of the European Society of Cardiology (ESC).1 This was the first study to compare the rates of primary percutaneous coronary intervention (PCI) in heart attack patients with and without cancer, and to examine the comparative effectiveness and safety of treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2021 Category: Cancer & Oncology Source Type: news